0.05Open0.05Pre Close10 Volume307 Open Interest2.50Strike Price50.00Turnover843.29%IV924.10%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier16DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.3456Delta0.8273Gamma4.99Leverage Ratio-0.0050Theta0.0000Rho1.73Eff Leverage0.0002Vega
Syros Pharmaceuticals Stock Discussion
👀
I'm wondering if Oxford Finance will demand immediate payment on the loan or if they will give some support by negotiating the loan? I don't know much. How likely are the odds on these 2?
Will the share price go to zero?
Syros Announces Topline Data From Select-Mds-1 Phase 3 Trial of Tamibarotene in Higher-Risk Myelodysplastic Syndrome With Rara Gene Overexpression! Did not meet endpoint!
No comment yet